Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Neuroendocrine differentiation in gastric adenocarcinomas. An immunohistochemical study.

Blumenfeld W, Chandhoke DK, Sagerman P, Turi GK.

Arch Pathol Lab Med. 1996 May;120(5):478-81.

PMID:
8639052
2.

Detection of chromogranin A in human gastric adenocarcinomas using a sensitive immunohistochemical technique.

Qvigstad G, Sandvik AK, Brenna E, Aase S, Waldum HL.

Histochem J. 2000 Sep;32(9):551-6.

PMID:
11127976
3.

The frequency and clinical significance of neuroendocrine cells within stage III adenocarcinomas of the colon.

Foley EF, Gaffey MJ, Frierson HF Jr.

Arch Pathol Lab Med. 1998 Oct;122(10):912-4.

PMID:
9786353
4.

Neuroendocrine differentiation in gastric adenocarcinomas associated with severe hypergastrinemia and/or pernicious anemia.

Qvigstad G, Qvigstad T, Westre B, Sandvik AK, Brenna E, Waldum HL.

APMIS. 2002 Feb;110(2):132-9.

PMID:
12064868
5.

Neuroendocrine differentiation in gastric adenocarcinomas; correlation with tumor stage and expression of VEGF and p53.

Eren F, Celikel C, Güllüoğlu B.

Pathol Oncol Res. 2004;10(1):47-51. Epub 2004 Mar 18.

6.

Hep Par 1 in gastric and bowel carcinomas: an immunohistochemical study.

Villari D, Caruso R, Grosso M, Vitarelli E, Righi M, Barresi G.

Pathology. 2002 Oct;34(5):423-6.

PMID:
12408340
7.
8.

Neuroendocrine differentiation in 32 cases of so-called sclerosing hemangioma of the lung: identified by immunohistochemical and ultrastructural study.

Xu HM, Li WH, Hou N, Zhang SG, Li HF, Wang SQ, Yu ZY, Li ZJ, Zeng MY, Zhu GM.

Am J Surg Pathol. 1997 Sep;21(9):1013-22.

PMID:
9298877
11.

Neuroendocrine differentiation in human gastric carcinoma.

Waldum HL, Aase S, Kvetnoi I, Brenna E, Sandvik AK, Syversen U, Johnsen G, Vatten L, Polak JM.

Cancer. 1998 Aug 1;83(3):435-44.

PMID:
9690535
12.

Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma.

Aprikian AG, Cordon-Cardo C, Fair WR, Reuter VE.

Cancer. 1993 Jun 15;71(12):3952-65.

13.
14.

Prevalence and prognostic significance of neuroendocrine cells in esophageal adenocarcinoma.

Hamilton K, Chiappori A, Olson S, Sawyers J, Johnson D, Washington K.

Mod Pathol. 2000 May;13(5):475-81.

15.

Neuroendocrine stains and proliferative indices of prostatic adenocarcinomas in transurethral resection samples.

Speights VO Jr, Cohen MK, Riggs MW, Coffield KS, Keegan G, Arber DA.

Br J Urol. 1997 Aug;80(2):281-6.

PMID:
9284203
16.

Neuroendocrine differentiation in cervical carcinoma.

Savargaonkar PR, Hale RJ, Mutton A, Manning V, Buckley CH.

J Clin Pathol. 1996 Feb;49(2):139-41.

17.

Neuroendocrine differentiation and prognosis in prostatic adenocarcinoma.

McWilliam LJ, Manson C, George NJ.

Br J Urol. 1997 Aug;80(2):287-90.

PMID:
9284204
20.

Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma.

Oue N, Mitani Y, Aung PP, Sakakura C, Takeshima Y, Kaneko M, Noguchi T, Nakayama H, Yasui W.

J Pathol. 2005 Oct;207(2):185-98.

PMID:
16086444
Items per page

Supplemental Content

Write to the Help Desk